H. michael shepard
WebDr Shepard is a board certified Orthopaedic Surgeon who is subspecialty trained in sports medicine with special emphasis on the care of the overhead athlete and knee ligament reconstruction. Awards View Profile Services Michael Shepard, MD specializes in orthopaedic surgery. H. Michael Shepard is an American cancer researcher who was awarded the 2024 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin See more Shepherd holds a bachelor's degree from the University of California, Davis, and a Ph.D. from Indiana University. Dr. Shepard was a Damon Runyon Cancer Research Foundation Fellow at Indiana University. His introduction to … See more Shepard has made seminal contributions to gene therapy of cancer, to tumor suppressor gene targeted small molecule therapeutics, and to drugs which target the tumor extracellular matrix. He continues his work, now expanding successful treatment … See more • Receptor Biologix • Alpert Foundation See more Following Ullrich's characterization of the HER2 protooncogene, Shepard collaborated with Ullrich and Slamon to explore possible links to breast cancer. Slamon discovered, along with other colleagues in the field, that HER2 overexpression in … See more • U.S. Patent 7,138,388 — Methods to treat autoimmune and inflammatory conditions • U.S. Patent 7,105,156 — Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells See more
H. michael shepard
Did you know?
WebMar 28, 2024 · The estimated net worth of H. Michael Shepard is at least $456,519 dollars as of 2024-03-21. H. Michael Shepard is the VP, Chief Scientific Officer of Halozyme Therapeutics Inc and owns about 13,198 shares of Halozyme Therapeutics Inc (HALO) stock worth over $456,519. Details can be seen in H. Michael Shepard's Latest Holdings … WebOct 16, 2024 · H Michael Shepard, PhD San Juan Unified School District 1.81K subscribers Subscribe 1 Share 80 views 3 years ago H Michael Shepard, PhD - Evening with the …
WebSep 11, 2013 · H. Michael Shepard's largest sale order was 10,000 units, worth over $71.09K on September 11, 2013. In total, H. Michael Shepard has made about 7 transactions over 2 years of their time ... WebDirector of State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology; Chief Scientist of a “973 Program”; Awardee of the National Science Fund for Distinguished Young Scholars, China Jin Ren Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Yingping Zhuang
WebH. MICHAEL SHEPARD, Ph.D. Dr. Shepard was appointed to EXUMA’S Scientific Advisory Board in May 2024. At Genentech, he and a team of researchers discovered Herceptin … WebH. Michael Shepard is an American cancer researcher who was awarded the 2024 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin[1] For faster navigation, this Iframe is preloading the Wikiwand page for H. Michael Shepard .
WebSep 25, 2024 · Quick Summary. UC Davis alumnus H. Michael Shepard last Friday (Sept. 20) received one of the 2024 Lasker Awards, widely considered America’s top biomedical research prizes. He and two colleagues, Dennis J. Slamon and Axel Ullrich, shared the Lasker~DeBakey Clinical Medical Research Award and a $250,000 honorarium for their …
WebH. Michael Shepard. Age : 72. Linked companies : Pascal Biosciences Inc. Summary. H. Michael Shepard founded Receptor BioLogix, Inc. and Enosi Life Sciences Corp. Currently, he is President, Director & Chief Scientific Officer at Enosi Life Sciences Corp. He is also on the board of Pascal Biosciences, Inc. In the past Dr. Shepard occupied the ... foodsource lure corporationWebShepard was also scientific program leader for Halozyme’s Phase 3 candidate for pancreatic cancer (Pegylated PH20 hyaluronidase). Shepard currently consults with … food source on marsWebSep 10, 2024 · Shepard—an innovator in the field of biotechnology and pioneer in cancer research—earned his Ph.D. in molecular, cellular and developmental biology in 1977 from … electric bikes decathlonWebJun 24, 2024 · Dr. Shepard is a winner of the 2024 Lasker Award for his role in developing Herceptin ®, a lifesaving therapy for women with HER2-positive breast cancer that has been used to treat more than 2.3... electric bikes darlingtonWebOct 1, 2024 · H. Michael Shepard, Dennis Slamon, and Axel Ullrich are being recognized for their work toward the development of Herceptin, the first targeted-mAb therapy for cancer. Photo of Axel Ullrich courtesy of the Mary and Albert Lasker Foundation. The hunt for cancer-causing genes and therapeutic strategies electric bikes cycle schemeWebH. Michael Shepard. Adjunct Professor, Biology. Office Hours M-F By Appointment Only. Education. Walter Winchell-Damon Runyon postdoctoral fellowship, Indiana University Department of Biology; Ph.D., Indiana University Department of Biology, 1977; About Mike Shepard. NOTE: Shepard is an adjunct faculty member ... food source of thiaminWebH. Michael Shepard is an American cancer researcher who was awarded the 2024 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their … electric bikes cycle to work